In the United States, bladder cancer has emerged as one of the most financially burdensome malignancies, with treatment costs projected to have exceeded $6.5 billion in 2021. This impact is due to an aging population, advances in healthcare tech, and the disease’s chronic nature. Bladder cancer predominantly affects older adults,[Read More…]